Dado que la tirzepatida acta como un agonista dual de los receptores GIP y GLP-1, se cree que podra ofrecer beneficios adicionales al estimular mltiples hormonas endgenas implicadas en la regulacin energtica (Jastreboff et al., 2022)
Terrible instructions in kit
Takuya Sugiyama of the Department of Endocrinology and Metabolism, Sumitomo Hospital, and Dr
These advancements position microneedle technology as a transformative approach for delivering GLP-1 receptor agonists, offering the potential to improve therapeutic adherence, minimize systemic side effects, and support decentralized care models for diabetes management [43]
Some patients prefer morning administration to allow any mild nausea to resolve during the day, while others may prefer evening injection if they experience fatigue or other symptoms following administration
6.9% of people on Wegovy in clinical trials who had type 2 diabetes experienced retinal disorders compared to 4.2% on placebo primarily diabetic retinopathy and non-proliferative retinopathy
